The form states: “By daily living we mean preparing food and cooking, eating and drinking, managing treatments and taking medication ... will be on the letter and the review form.

CRL focused on CMC; no clinical issues relating to etripamil raised$69.7M in cash, cash equivalents and short-term investments as of December 31, ...

Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...